Book a demo

Chemical intelligence powered by cypris.ai

2-hydroxy-6-pentadeca-8,11,14-trienylbenzoic acid

2-hydroxy-6-pentadeca-8,11,14-trienylbenzoic acid · also: 2-hydroxy-6-pentadeca-8,11,14-trienyl benzoic acid

FormulaC22H30O3
Mol. weight342.479
PubChem CID152243
InChIKeyQUVGEKPNSCFQIR-UHFFFAOYSA-N
SMILESC=CCC=CCC=CCCCCCCCC1=C(C(=CC=C1)O)C(=O)O
1,857Patents
109Research papers
167Patents - last 3 years
0Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1Nestec SA101
2Societe des Produits Nestle SA60
3Zevra Therapeutics Inc57
4Dow Global Technologies LLC54
5Idemitsu Kosan Co Ltd48
6SDS Biotech Corp34
7Innophos Inc22
83M Innovative Properties Co21
9Centre National de la Recherche Scientifique20
10Indian Oil Corp Ltd20

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1A61KMedicinal preparations768
2A61PTherapeutic activity (drug indications)665
3C08GPolymers from non-vinyl bonds (e.g. polyamides, polyesters)365
4C08LPolymer compositions (blends)274
5C07DHeterocyclic compounds219
6A23LFoods and beverages (general)212
7C09DCoatings, paints, varnishes189
8C07CAcyclic and carbocyclic compounds165
9A23VFoods, foodstuffs - indexing scheme139
10C08KPolymer compositions (additives)139

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Where research is gaining momentum

Research themes ranked by publication activity show where scientific interest is accelerating around this compound.

#Research topicPapers
1Bioactive Compounds and Antitumor Agents1
2Ginkgo biloba and Cashew Applications1

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1Isao KuboUniversity of California, Berkeley8
2A. Srinivasa RaoVittal Mallya Scientific Research Foundation5
3Antonello MaiSapienza University of Rome5
4Lucia AltucciUniversity of Naples Federico II5
5P. Phani KumarVittal Mallya Scientific Research Foundation5
6Gianluca SbardellaUniversity of Salerno4
7R. ParamashivappaVittal Mallya Scientific Research Foundation4
8Angela NebbiosoUniversity of Naples Federico II3
9Caterina VicidominiUniversity of Salerno3
10Frank J. DekkerUniversity of Groningen3

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the molecular formula and weight of 2-hydroxy-6-pentadeca-8,11,14-trienylbenzoic acid?

2-hydroxy-6-pentadeca-8,11,14-trienylbenzoic acid has the molecular formula C22H30O3 and a molecular weight of 342.479 g/mol.

Which organizations hold the most patents related to this compound?

Nestec SA leads with 101 patents, followed by Societe des Produits Nestle SA with 60 patents and Zevra Therapeutics Inc with 57 patents. Other significant patent holders include Dow Global Technologies LLC with 54 patents and Idemitsu Kosan Co Ltd with 48 patents.

What are the primary research areas associated with this compound based on scientific literature?

Research on this compound spans Bioactive Compounds and Antitumor Agents, as well as Ginkgo biloba and Cashew Applications. The literature also covers topics including histone acetyltransferase modulation, protein SUMOylation, and antioxidant activities.

How has patent activity for this compound trended in recent years?

Patent filings peaked at 178 in 2021 and 170 in 2023. Activity in 2022 was 121 patents, and 2024 saw 96 patents through the data collection period. Notably, 2020 marked an increase to 135 patents compared to prior years ranging from 85 to 101.

What are the dominant patent classification areas for this compound?

The compound appears most frequently under pharmaceutical and chemical patents. Class A61K (pharmaceuticals) has 768 patents, A61P (pharmaceutical uses) has 665 patents, and C08G (polymers) has 365 patents. Other significant classifications include C08L with 274 patents and C07D with 219 patents.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial